Cheaper and not worse
Cultured meat from Tiamat Sciences will be several times cheaper than real meat
Stepan Ikaev, Hi-tech+
Biotech startup Tiamat Sciences is developing a new environment for growing meat without slaughter. The startup specializes in creating growth factors that can stimulate the development of living cells. Tiamat Sciences expects to develop molecules that will replace existing reagents and make the production of cultured meat cheaper than it is obtained by raising livestock and poultry in conventional animal husbandry.
According to the estimates of the founder and CEO of Tiamat Sciences, France-Emmanuel Adil, the actual production of growth factors costs $2 million per gram today. The high cost of this process also increases the price of cultured meat — a product grown in the laboratory from the cells of real animals. Tiamat Sciences claims to know how to make growth factors significantly cheaper — the startup is ready to reduce the cost of production by 10 times in the coming months, and then make growth factors available to almost any manufacturer — 1000 times cheaper by 2025, Techcrunch reports.
Tiamat Sciences' patented platform uses temporal expression, vertical cultivation, and a data-driven approach to develop and produce next-generation proteins. Now this system is at the stage of closed trials — the startup does not disclose details about its technology and promises to tell more when the first production facility in Durham, North Carolina, is launched.
The list of Tiamat Sciences' clients is also kept secret, but, according to Adil, the first companies have already ordered test samples of growth factors and expect to receive them by the end of the year. When the first products are tested, the startup will proceed to the conclusion of partnership agreements. In addition to food, Taimat Sciences' approach will also be applied in pharmaceuticals — the developer company calls vaccine production and regenerative medicine important industries for its key products.
"Growth factors can be transferred to other industries, because the processes are similar. We will work on the expansion until the end of 2022. And we will scale very quickly," Adil added.
Tiamat Sciences recently raised $3 million in seed funding in a round led by the True Ventures fund with the participation of Social Impact Capital and Cantos. Before the seed investments, the startup managed to close a small round for $ 400 thousand and move its headquarters from Belgium to North Carolina. Now Tiamat Sciences is looking for partners to build the first experimental production.
Portal "Eternal youth" http://vechnayamolodost.ru